Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Dapagliflozin reduces systemic inflammation in patients w... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Dapagliflozin reduces systemic inflammation in patients with type 2 diabetes without known heart failure
0
Authors
Dennis Wang
13 more
Dennis Wang
•
Anna Naumova
11 more
•
Francis Kim
Published
June 7, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Cardiovascular Diabetology
Topics
Medicine
Pathology
Internal Medicine
Endocrinology
Cardiology
Show all topics
DOI
10.1186/s12933-024-02294-z
License
CC-BY
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Cardiovascular Diabetology
Topics
Medicine
Pathology
Internal Medicine
Endocrinology
Cardiology
Show all topics
DOI
10.1186/s12933-024-02294-z
License
CC-BY
Other Formats
PDF
